Phenylalanine monooxygenase and the sulfur oxygenation of S-carboxymethyl-l-cysteine in mice

References

• Aiache JM, Borel JP, Kantelip JP. (1982). Comparative bioavailability of S-carboxymethyl-l-cysteine from two dosage forms: hard gelatin capsule and syrup. Biopharm Drug Dispos 9:275–81
   Web of Science ®Google Scholar
• Allard P, Cowell LD, Zytkovicz TH, et al. (2004). Determination of phenylalanine and tyrosine in dried blood specimens by ion-exchange chromatography using the Hitachi L-8800 analyzer. Clin Biochem 37:857–62
   PubMed Web of Science ®Google Scholar
• Berk (1973). Monograph on S-Carboxymethyl-l-cysteine. Guildford, Surrey, UK: Berk Pharmaceuticals Limited
   Google Scholar
• Boonyapiwat B, Forbes B, Mitchell SC, Steventon GB. (2008). Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-l-cysteine by human cytosolic fractions. Drug Metab Drug Inter 23:261–82
   PubMedGoogle Scholar
• Boonyapiwat B, Forbes B, Steventon GB. (2004). Phenylalanine hydroxylase: possible involvement in the S-oxidation of S-carboxymethyl-l-cysteine. Anal Biochem 335:91–7
   PubMed Web of Science ®Google Scholar
• Boonyapiwat B, Mitchell SC, Steventon GB. (2011). Recombinant heteromeric phenylalanine monooxygenase and the oxygenation of carbon and sulfur substrates. J Pharm Pharmacol 63:558–64
   PubMed Web of Science ®Google Scholar
• Boonyapiwat B, Panagopoulos P, Jones H, et al. (2005). Phenylanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-l-cysteine in HepG2 cells. Drug Metab Drug Inter 21:1–18
   PubMed Web of Science ®Google Scholar
• Boonyapiwat B, Panaretou B, Forbes B, et al. (2009). Human phenylalanine monooxygenase and thioether metabolism. J Pharm Pharmacol 61:63–7
   PubMed Web of Science ®Google Scholar
• Brandolini L, Allegeretti M, Berdini V, et al. (2003). Carbocysteine lysine salt monohydrate (SCMC-LYS) is a selective scavenger of reactive oxygen intermediates (ROIs). Eur Cytokine Netw 14:20–6
   PubMed Web of Science ®Google Scholar
• Brow DT. (1988). Carbocysteine. Drug Intell Clin Pharm 22:603–8
   PubMedGoogle Scholar
• Castells S, Shirali S. (1971). Daily rhythmic changes in hepatic phenylalanine hydroxylase activity: role of dietary phenylalanine. Life Sci (part 2) 10:233–9
   PubMed Web of Science ®Google Scholar
• Cavanaugh DJ. (1957). Oxidation of chlorpromazine by peroxidase and catalase. Science 125:1040–1
   PubMed Web of Science ®Google Scholar
• De Person M, Chaimbault P, Elfakir C. (2008). Analysis of native amino acids by liquid chromatography/electrospray ionization mass spectrometry: comparative study between two sources and interfaces. J Mass Spectrom 43:204–15
   PubMed Web of Science ®Google Scholar
• Dreyer G, Ray W. (1911). The blood volume of mammals as determined by experiments upon rabbits, guinea-pigs, and mice; and its relationship to the body weight and to the surface area expressed in a formula. Phil Trans Roy Soc Lond, Ser B 201:133–60
   Google Scholar
• Egan RW, Gale PH, Kuehl Jr FA. (1979). Reduction of hydroperoxides in the prostaglandin biosynthetic pathway by a microsomal peroxidase. J Biol Chem 254:3295–302
   PubMed Web of Science ®Google Scholar
• Egan RW, Gale PH, Vanden Heuvel WJ, et al. (1980). Mechanism of oxygen transfer by prostaglandin hydroperoxidase. J Biol Chem 255:323–6
   PubMed Web of Science ®Google Scholar
• Gersting SW, Lagler FB, Eichinger A, et al. (2010). Pahenu1 is a mouse model for tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency and promotes analysis of the pharmacological chaperone mechanism in vivo. Hum Mol Genet 19:2039–49
   PubMed Web of Science ®Google Scholar
• Goreish AH, Bednar S, Jones H, et al. (2004). Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-l-cysteine. Drug Metab Drug Inter 20:159–74
   PubMedGoogle Scholar
• Hoang L, Byck S, Prevost L, Scriver CR. (1996). PAH mutation analysis consortium database: a database for disease-producing and other allelic variations at the human PAH locus. Nucleic Acids Res 24:127–31
   PubMed Web of Science ®Google Scholar
• Hoff J. (2000). Methods of blood collection in the mouse. Lab Animal 29:47–53
   Web of Science ®Google Scholar
• Hooper C, Calvert J. (2008). The role for S-carboxymethylcycteine (carbocisteine) in the management of chronic obstructive pulmonary disease. Internat J COPD 3:659–69
   Google Scholar
• Kaufman S, Fisher DB. (1974). Pterin-requiring aromatic amino acid hydroxylases. In: Hayaishi O, ed. Molecular mechanism of oxygen activation. London: Academic Press, 285–369
   Google Scholar
• Kaufman S, Mason K. (1982). Specificity of amino acids as activators and substrates for phenylalanine hydroxylase. J Biol Chem 257:14667–78
   PubMed Web of Science ®Google Scholar
• Kupfer A, Gerber F, Hanser E, et al. (1991). Phenocopy of extensive carbocysteine metabolism by acetyl cysteine co-administration in poor metaboliser subjects. Experientia 47:A29
   Google Scholar
• Kupfer A, Idle JR. (1990). False positives with current carbocysteine protocol for sulphoxidation phenotyping. Lancet 335:1107
   PubMed Web of Science ®Google Scholar
• Lagler FB, Gersting SW, Zsifkovits C, et al. (2010). New insights into tetrahydrobiopterin pharmacodynamics from Pahenu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Biochem Pharmacol 80:1563–71
   PubMed Web of Science ®Google Scholar
• Matthews DE. (2007). An overview of phenylalanine and tyrosine kinetics in humans. J Nutr 137:1549S–55S
   PubMed Web of Science ®Google Scholar
• May SW, Phillips RS. (1980). Asymmetric sulfoxidation by dopamine-β-hydroxylase, an oxygenase heretofore considered specific for methylene hydroxylation. J Am Chem Soc 102:5981–3
   Web of Science ®Google Scholar
• May SW, Phillips RS, Mueller PW, Herman HH. (1981). Dopamine beta-hydroxylase. Comparative specificities and mechanisms of the oxygenation reactions. J Biol Chem 256:8470–5
   PubMed Web of Science ®Google Scholar
• McDonald JD, Bode VC, Dove WF, Shedlovsky A. (1990). Pah(hph5): a mouse mutant deficient in phenylalanine hydroxylase. Proc Natl Acad Sci USA 87:1965–7
   PubMed Web of Science ®Google Scholar
• McDonald JD, Charlton CK. (1997). Characterisation of mutations at the mouse phenylalanine hydroxylase locus. Genomics 39:402–5
   PubMed Web of Science ®Google Scholar
• Meese CD. (1987). S-carboxymethyl-l-cystein-(R)- un (S)-Sulphoxid. Arch Pharm (Weinheim) 320:473–4
   Web of Science ®Google Scholar
• Meese CO, Specht D, Hofmann U. (1990). Syntheses of metabolites of S-carboxymethyl-l-cysteine and S-methyl-l-cysteine and of some isotopically labelled (2H, 13C) analogues. Arch Pharm (Weinheim) 323:957–65
   PubMed Web of Science ®Google Scholar
• Meese CO, Specht D, Ratge D, et al. (1993). High-performance liquid chromatographic and carbon-13 nuclear magnetic resonance spectrometric determination of S-carboxymethyl-l-cysteine and its metabolites in human urine. Fresenius J Anal Chem 346:837–40
   Google Scholar
• Mitchell SC. (1988). Biological consequences of drug sulphoxidation. Drug Metab Drug Interact 6:245–52
   PubMedGoogle Scholar
• Mitchell SC, Idle JR, Smith RL. (1982a). The metabolism of [14C]-cimetidine in man. Xenobiotica 12:283–92
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Idle JR, Smith RL. (1982b). Reductive metabolism of cimetidine sulphoxide in man. Drug Metab Dispos 10:289–90
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Steventon GB. (2012). S-Carboxymethyl-l-cysteine. Drug Metab Rev 44:129–47
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Waring RH. (1989a). The deficiency of sulfoxidation of S-carboxymethyl-l-cysteine. Pharmacol Therap 43:237–49
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Waring RH. (1989b). The fate of cimetidine sulphoxide in the guinea pig. Xenobiotica 19:179–88
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Waring RH, Haley CS, et al. (1984). Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-l-cysteine in man. Brit J Clin Pharmacol 18:507–21
   PubMed Web of Science ®Google Scholar
• Nickson RM, Mitchell SC. (1994). Fate of dipropyl sulphide and dipropyl sulphoxide in rat. Xenobiotica 24:157–68
   PubMed Web of Science ®Google Scholar
• Nickson RM, Mitchell SC, Zhang AQ. (1995). Fate of dipropyl sulphone in rat. Xenobiotica 25: 1391–98
   PubMed Web of Science ®Google Scholar
• Panagopoulos P. (2008). The metabolism and pharmacokinetics of S-carboxymethyl-l-cysteine in large mammalian species [PhD thesis]. London (UK): King’s College
   Google Scholar
• Panagopoulos P, Forbes B, Mitchell SC, Steventon GB. (2010). The pharmacokinetics of orally administered S-carboxymethyl-l-cysteine in the dog, calf and sheep. Eur J Pharm Sci 39:219–23
   PubMed Web of Science ®Google Scholar
• Patel GL, Illoudi C, Boonyapiwat B, et al. (2008). Enzyme kinetic and molecular modelling studies of sulphur containing substrates of phenylalanine 4-monooxygenase. J Enz Inhib Med Chem 23:958–63
   PubMed Web of Science ®Google Scholar
• Paxson CL, Smith LH. (1968). Blood volume of the mouse. Expt Haemat 17:42–7
   Google Scholar
• Piraud M, Viany-Saban C, Petritis K, et al. (2003). ESI-MS/MS analysis of underivatised amino acids: a new tool for the diagnosis of inherited disorders of amino acid metabolism. Fragmentation study of 79 molecules of biological interest in positive and negative ionisation mode. Rapid Commun Mass Spectrom 17:1297–311
   PubMed Web of Science ®Google Scholar
• Renwick AG. (1996). Sulfur-oxygen compounds. In: Mitchell SC, ed. Biological interactions of sulfur compounds. London: Taylor and Francis, 42–76
   Google Scholar
• Riches AC, Sharp JG, Brynmor Thomas D, Vaughan Smith S. (1973). Blood volume determination in the mouse. J Physiol 228:279–84
   PubMed Web of Science ®Google Scholar
• Sarkissian CN, Boulais DM, McDonald JD, Scriver CR. (2000). A heteroallelic mutant mouse model: a new orthologue for human hyperphenylalaninemia. Mol Genet Metab 69:188–94
   PubMed Web of Science ®Google Scholar
• Sarkissian CN, Ying M, Scherer T, et al. (2012). The mechanism of BH4-responsive hyperphenylalaninemia – as it occurs in the ENU1/2 genetic mouse model. Hum Mutat 33:1464–73
   PubMed Web of Science ®Google Scholar
• Shedlovsky A, McDonald JD, Symula D, Dove WF. (1993). Mouse models of human phenylketonuria. Genetics 134:1205–10
   PubMed Web of Science ®Google Scholar
• Song Y, Lu HZ, Xu JR, et al. (2015). Carbocysteine restores steroid sensitivity by targeting histone deacetylase 2 in a thiol/GSH-dependent manner. Pharmacol Res 91:88–98
   PubMed Web of Science ®Google Scholar
• Steventon GB. (1998). A methodological and metabolite identification study of the metabolism of S-carboxymethyl-l-cysteine in man. Chromatographia 48:561–8
   Web of Science ®Google Scholar
• Steventon GB. (1999). Diurnal variation in the metabolism of S-carboxymethyl-l-cysteine in man. Drug Metab Disp 27:1092–7
   PubMed Web of Science ®Google Scholar
• Steventon GB, Mitchell SC, Pérez B, et al. (2009). The activity of wild type and mutant phenylalanine hydroxylase with respect to the C-oxidation of phenylalanine and the S-oxidation of S-carboxymethyl-l-cysteine. Mol Genet Metab 96:27–31
   PubMed Web of Science ®Google Scholar
• Sullivan D, Carver MJ, Copenhaver JH. (1972). Daily variations in phenylalanine hydroxylase activity in male and female guinea pig. Life Sci (part 2) 11:533–9
   Web of Science ®Google Scholar
• van Spronsen FJ. (2010). Phenylketonuria: a 21st century perspective. Nat Rev Endocrinol 6:509–14
   PubMed Web of Science ®Google Scholar
• Yageta Y, Ishii Y, Morishima Y, et al. (2014). Carbocisteine reduces virus-induced pulmonary inflammation in mice exposed to cigarette smoke. Am J Resp Cell Mol Biol 50:963–73
   PubMed Web of Science ®Google Scholar